+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pneumococcal Vaccine Market - Global Forecast 2026-2032- Product Image
Pneumococcal Vaccine Market - Global Forecast 2026-2032- Product Image
New

Pneumococcal Vaccine Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968848
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pneumococcal vaccine market is experiencing rapid transformation driven by innovation, regulatory change, and the evolution of healthcare delivery. Senior decision-makers must understand how these forces interact to capture growth opportunities and address shifting market requirements.

Pneumococcal Vaccine Market Snapshot: Size and Growth Outlook

The pneumococcal vaccine market is projected to grow from USD 12.49 billion in 2025 to USD 13.45 billion in 2026, advancing at a CAGR of 8.18% and reaching USD 21.67 billion by 2032. This expansion reflects global efforts to promote immunization, persistent innovation in vaccine science, and rising uptake across multiple patient groups. Emerging market potential is encouraged by expanding healthcare access, supportive policy environments, and the integration of digital health solutions, positioning the sector for dynamic growth.

Pneumococcal Vaccine Market: Scope & Segmentation

  • Vaccine Modalities: Segments include conjugate and polysaccharide vaccines, with continued emphasis on broadening serotype protection and developing improved formulations for children, adults, and elderly populations.
  • Lifecycle Age Groups: End users span pediatric, adult, and senior cohorts, each requiring customized clinical approaches and distribution pathways based on risk assessment and healthcare system capacity.
  • Distribution Channels: Vaccines are delivered via clinics, hospitals, immunization centers, ambulatory providers, and through digital appointment systems which facilitate patient access and increase adherence rates.
  • Regional Coverage: The market is shaped by distinct regional dynamics: the Americas, Europe Middle East & Africa, and Asia-Pacific each present unique regulatory challenges, procurement models, and logistics, necessitating region-specific strategies.
  • Technology Innovations: Sector growth is supported by advances such as new conjugate vaccine formulations, dose-sparing technology, greater thermostability, and scalable production platforms, enhancing accessibility and efficiency.
  • Stakeholder Types: Stakeholders include manufacturers, healthcare providers, payers, regulators, and purchasing agencies, each influencing development, supply chain strategy, and end-user engagement.

Key Takeaways

  • Life-course immunization frameworks are expanding vaccine access, integrating prevention throughout adulthood and not just childhood, to address a broader spectrum of chronic and infectious diseases.
  • Manufacturers are prioritizing innovation to extend vaccine coverage and streamline distribution chains, strengthening responsiveness to public health risks and fluctuating demand patterns.
  • Partnerships and technology transfer arrangements are essential for securing supply continuity and managing procurement risk, particularly during periods of regulatory adjustment or global trade disruption.
  • Digital technologies are improving operational efficiency and outreach, making patient engagement and resource allocation more robust in highly connected regions.
  • Distinctive regional trends guide market approaches: established procurement channels drive efficiency in the Americas, cost considerations weigh heavily in Europe Middle East & Africa, while Asia-Pacific’s varied distribution landscape encourages flexible adaptation.

Tariff Impact on Supply Chains

Shifts in U.S. trade policies and tariff structures have prompted companies to redesign supply chain strategies. Building redundancy, relocating production closer to end markets, renegotiating supplier relationships, and accelerating technology transfers now underpin efforts to achieve reliable delivery and manage cost exposures linked to fluctuating tariffs. These adaptive measures are critical to sustaining vaccine availability and minimizing supply disruptions amid regulatory volatility.

Methodology & Data Sources

This report integrates insights from primary interviews with clinical experts, supply chain specialists, and procurement leaders, supplemented by comprehensive literature review, regulatory analysis, and established public health guidance. Segmentation analysis and strategic scenario planning were corroborated in expert-led workshops to enhance reliability for executive decision-making.

Why This Report Matters

  • Provides senior decision-makers with clear direction on emerging demand drivers, technology advancement, and evolving regulatory policies relevant to the pneumococcal vaccine market.
  • Helps guide operational and investment strategies by identifying effective procurement, manufacturing, and market access responses to shifting policy and trade conditions.
  • Delivers actionable frameworks to align product development and distribution with regional requirements and diverse stakeholder priorities.

Pneumococcal Vaccine Market: Concluding Perspectives

Uniting clinical innovation, operational resilience, and broad market access will determine success in the evolving pneumococcal vaccine space. Stakeholders focused on adaptive execution and technology-driven strategies will be best positioned to achieve both health and operational objectives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Pneumococcal Vaccine Market, by Vaccine Type
8.1. Conjugate Vaccine
8.1.1. Pcv13
8.1.2. Pcv15
8.1.3. Pcv20
8.2. Polysaccharide Vaccine
9. Pneumococcal Vaccine Market, by Age Group
9.1. Adult
9.2. Children
9.3. Geriatric
10. Pneumococcal Vaccine Market, by Distribution Channel
10.1. Offline
10.2. Online
11. Pneumococcal Vaccine Market, by End User
11.1. Ambulatory Care Centers
11.2. Clinics
11.3. Hospitals
11.4. Immunization Centers
12. Pneumococcal Vaccine Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Pneumococcal Vaccine Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Pneumococcal Vaccine Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Pneumococcal Vaccine Market
16. China Pneumococcal Vaccine Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott
17.6. Astellas Pharma Inc.
17.7. Beijing Minhai Biotechnology Co., Ltd.
17.8. Bharat Biotech International Ltd.
17.9. Biological E. Limited
17.10. BioNTech SE
17.11. GSK plc
17.12. Inventprise LLC
17.13. KM Biologics Co., Ltd.
17.14. LG Chem Ltd.
17.15. Merck & Co., Inc.
17.16. Novartis AG
17.17. Panacea Biotec Ltd.
17.18. Pfizer Inc.
17.19. Pnuvax Incorporated
17.20. Sanofi S.A.
17.21. Serum Institute of India Pvt. Ltd.
17.22. Shenzhen Kangtai Biological Products Co., Ltd.
17.23. SK Bioscience Co., Ltd.
17.24. Vaxcyte Inc.
17.25. Walvax Biotechnology Co., Ltd.
List of Figures
FIGURE 1. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PNEUMOCOCCAL VACCINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PNEUMOCOCCAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV13, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV13, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV13, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV15, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV15, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV15, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV20, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV20, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PCV20, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CHILDREN, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CHILDREN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CHILDREN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY IMMUNIZATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY IMMUNIZATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY IMMUNIZATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 51. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 52. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 53. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 54. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 56. NORTH AMERICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. NORTH AMERICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 58. NORTH AMERICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 59. NORTH AMERICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 60. NORTH AMERICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 61. NORTH AMERICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 62. LATIN AMERICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. LATIN AMERICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 64. LATIN AMERICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 65. LATIN AMERICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 66. LATIN AMERICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 67. LATIN AMERICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 76. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 77. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 78. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. EUROPE PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. MIDDLE EAST PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. MIDDLE EAST PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 82. MIDDLE EAST PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 83. MIDDLE EAST PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 84. MIDDLE EAST PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. MIDDLE EAST PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 88. AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 89. AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 90. AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. ASEAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. ASEAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 101. ASEAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 102. ASEAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 103. ASEAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 104. ASEAN PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. GCC PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GCC PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 107. GCC PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 108. GCC PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 109. GCC PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. GCC PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. EUROPEAN UNION PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. EUROPEAN UNION PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 113. EUROPEAN UNION PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 114. EUROPEAN UNION PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 115. EUROPEAN UNION PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. EUROPEAN UNION PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. BRICS PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. BRICS PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 119. BRICS PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 120. BRICS PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 121. BRICS PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 122. BRICS PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. G7 PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. G7 PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 125. G7 PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 126. G7 PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 127. G7 PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. G7 PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. NATO PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. NATO PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 131. NATO PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 132. NATO PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 133. NATO PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. NATO PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 137. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 138. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 139. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 140. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. UNITED STATES PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 143. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 144. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINE, 2018-2032 (USD MILLION)
TABLE 145. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 146. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. CHINA PNEUMOCOCCAL VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Pneumococcal Vaccine market report include:
  • Abbott
  • Astellas Pharma Inc.
  • Beijing Minhai Biotechnology Co., Ltd.
  • Bharat Biotech International Ltd.
  • Biological E. Limited
  • BioNTech SE
  • GSK plc
  • Inventprise LLC
  • KM Biologics Co., Ltd.
  • LG Chem Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Pnuvax Incorporated
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co., Ltd.
  • SK Bioscience Co., Ltd.
  • Vaxcyte Inc.
  • Walvax Biotechnology Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 13.45 Billion
Forecasted Market Value ( USD ) by 2032 $ 21.67 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Pneumococcal Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Pneumococcal Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Pneumococcal Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Pneumococcal Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
Pneumococcal Vaccine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Pneumococcal Vaccine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 130 Pages
  • Global
From
Pneumococcal Vaccine Market Report 2025 - Product Image

Pneumococcal Vaccine Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Pneumococcal Vaccines Market - Global Strategic Business Report - Product Image

Pneumococcal Vaccines Market - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From

About the Market

The Pneumococcal Vaccine is a type of vaccine used to protect against infection caused by the bacterium Streptococcus pneumoniae. It is used to prevent a range of illnesses, including pneumonia, meningitis, and sepsis. The vaccine is typically administered to infants and young children, as well as adults who are at an increased risk of infection. It is also recommended for adults over the age of 65. The Pneumococcal Vaccine market is a subset of the larger Vaccines market. It is a highly competitive market, with a number of companies offering different types of vaccines. These companies are typically involved in the research, development, and production of the vaccines. They also provide support services such as distribution, marketing, and education. Some of the companies in the Pneumococcal Vaccine market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.